Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antihypertensive agents AND cardiovascular event AND diastolic blood pressure AND systolic hypertension:

Search results

Items: 1 to 20 of 194

1.

Eplerenone for hypertension.

Tam TS, Wu MH, Masson SC, Tsang MP, Stabler SN, Kinkade A, Tung A, Tejani AM.

Cochrane Database Syst Rev. 2017 Feb 28;2:CD008996. doi: 10.1002/14651858.CD008996.pub2. Review.

PMID:
28245343
2.

Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study.

Lins R, Haerden Y, de Vries C.

High Blood Press Cardiovasc Prev. 2017 Mar;24(1):29-36. doi: 10.1007/s40292-016-0177-9.

PMID:
28058623
3.

Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.

Bangalore S, Fayyad R, Messerli FH, Laskey R, DeMicco DA, Kastelein JJ, Waters DD.

Am J Cardiol. 2017 Feb 1;119(3):379-387. doi: 10.1016/j.amjcard.2016.10.037. Epub 2016 Nov 4.

PMID:
27939230
4.

Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.

McEvoy JW, Martin SS, Dardari ZA, Miedema MD, Sandfort V, Yeboah J, Budoff MJ, Goff DC Jr, Psaty BM, Post WS, Nasir K, Blumenthal RS, Blaha MJ.

Circulation. 2017 Jan 10;135(2):153-165. doi: 10.1161/CIRCULATIONAHA.116.025471. Epub 2016 Nov 23.

5.

Blood Pressure Reduction and Secondary Stroke Prevention: A Systematic Review and Metaregression Analysis of Randomized Clinical Trials.

Katsanos AH, Filippatou A, Manios E, Deftereos S, Parissis J, Frogoudaki A, Vrettou AR, Ikonomidis I, Pikilidou M, Kargiotis O, Voumvourakis K, Alexandrov AW, Alexandrov AV, Tsivgoulis G.

Hypertension. 2017 Jan;69(1):171-179. Epub 2016 Oct 31. Review.

PMID:
27802419
6.

Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.

Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, Tendera M, Tavazzi L, Bhatt DL, Steg PG; CLARIFY Investigators.

Lancet. 2016 Oct 29;388(10056):2142-2152. doi: 10.1016/S0140-6736(16)31326-5. Epub 2016 Aug 30.

PMID:
27590221
7.

Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.

Myers MG, Kaczorowski J, Dolovich L, Tu K, Paterson JM.

Hypertension. 2016 Oct;68(4):866-72. doi: 10.1161/HYPERTENSIONAHA.116.07721. Epub 2016 Aug 15.

PMID:
27528062
8.

Women, Hypertension, and the Systolic Blood Pressure Intervention Trial.

Wenger NK, Ferdinand KC, Bairey Merz CN, Walsh MN, Gulati M, Pepine CJ; American College of Cardiology Cardiovascular Disease in Women Committee.

Am J Med. 2016 Oct;129(10):1030-6. doi: 10.1016/j.amjmed.2016.06.022. Epub 2016 Jul 15. Review.

PMID:
27427323
9.

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.

Weber MA, Bloch M, Bakris GL, Weir MR, Zappe DH, Dahlof B, Velazquez EJ, Pitt B, Basile JN, Jamerson K, Hua TA.

J Clin Hypertens (Greenwich). 2016 Apr;18(4):299-307. doi: 10.1111/jch.12816. Epub 2016 Mar 28.

10.

Current and Future Treatment of Hypertension in the SPRINT Era.

Phillips RA.

Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):206-13. doi: 10.14797/mdcj-11-4-206. Review.

11.

Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial.

Pajewski NM, Williamson JD, Applegate WB, Berlowitz DR, Bolin LP, Chertow GM, Krousel-Wood MA, Lopez-Barrera N, Powell JR, Roumie CL, Still C, Sink KM, Tang R, Wright CB, Supiano MA; SPRINT Study Research Group.

J Gerontol A Biol Sci Med Sci. 2016 May;71(5):649-55. doi: 10.1093/gerona/glv228. Epub 2016 Jan 11.

12.

Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trial.

Benitez-Camps M, Vinyoles-Bargalló E, Rebagliato-Nadal O, Morros-Pedrós R, Pera-Pujadas H, Dalfó-Baqué A, López-Pavón I, Roca-Sánchez C, Coma-Carbó RM, De La Figuera Von Wichmann M, Mengual-Martínez L, Yuste-Marco C, Teixidó-Colet M, Pepió i Vilaubí JM, Ciurana-Tost R, Pou-Vila R, Vila-Coll MA, Bordas-Julve JM, Aragonès-Forès R, Pelegrina-Rodríguez FJ, Agudo-Ugena J, Blanco-Mata C, de la Iglesia Berrojalbiz J, Burgos-Alonso N, Gómez-Fernández MC.

BMC Cardiovasc Disord. 2015 Dec 10;15:167. doi: 10.1186/s12872-015-0161-7.

13.

Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.

Mancia G, Kjeldsen SE, Zappe DH, Holzhauer B, Hua TA, Zanchetti A, Julius S, Weber MA.

Eur Heart J. 2016 Mar 21;37(12):955-64. doi: 10.1093/eurheartj/ehv633. Epub 2015 Nov 20.

PMID:
26590384
14.

Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment.

Lieb W, Enserro DM, Sullivan LM, Vasan RS.

J Am Heart Assoc. 2015 Nov 20;4(11). pii: e002155. doi: 10.1161/JAHA.115.002155.

15.

Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.

Hermida RC, Smolensky MH, Ayala DE, Portaluppi F.

Chronobiol Int. 2015;32(10):1329-42. doi: 10.3109/07420528.2015.1113804. Epub 2015 Nov 20.

PMID:
26587588
16.

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A.

Lancet. 2016 Jan 30;387(10017):435-43. doi: 10.1016/S0140-6736(15)00805-3. Epub 2015 Nov 7. Review.

PMID:
26559744
17.

Reducing the Blood Pressure-Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control.

Hardy ST, Loehr LR, Butler KR, Chakladar S, Chang PP, Folsom AR, Heiss G, MacLehose RF, Matsushita K, Avery CL.

J Am Heart Assoc. 2015 Oct 27;4(10):e002276. doi: 10.1161/JAHA.115.002276.

18.

Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels.

Karmali KN, Ning H, Goff DC, Lloyd-Jones DM.

J Am Heart Assoc. 2015 Sep 21;4(9):e002126. doi: 10.1161/JAHA.115.002126.

19.

A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly.

Yang W, Zhou YJ, Fu Y, Qin J, Qin S, Chen XM, Guo JC, Hua Q.

Am J Med Sci. 2015 Aug;350(2):109-15. doi: 10.1097/MAJ.0000000000000522.

PMID:
26164864
20.

Self-blood pressure monitoring in an urban, ethnically diverse population: a randomized clinical trial utilizing the electronic health record.

Yi SS, Tabaei BP, Angell SY, Rapin A, Buck MD, Pagano WG, Maselli FJ, Simmons A, Chamany S.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):138-45. doi: 10.1161/CIRCOUTCOMES.114.000950. Epub 2015 Mar 3.

Supplemental Content

Loading ...
Support Center